De Novo only exist in dreams when it come to Actipatch. This is not even the issue at hand. The reclassification killed that route completely and put it to bed.
it's a trip stock, of course it's a mess. based on company contact (which includes a visit with the company and not just emails), I think it is worth the risk right now. It certainly was a few years ago from the trip 4's to almost a penny.....
News 
Market Data 
Discover 
AI
